Enlivex LTD. (ENLV) SEC Filings — 2025
24 SEC filings for Enlivex LTD. (ENLV) in 2025.
Filings
- Enlivex Therapeutics LTD. 6-K Filing — 6-K · Dec 18, 2025
- Enlivex Therapeutics LTD. 6-K Filing — 6-K · Dec 4, 2025
- Enlivex Therapeutics Closes Private Placement — 6-K · Nov 26, 2025
- Enlivex Therapeutics LTD. 6-K Filing — 6-K · Nov 24, 2025
- Enlivex Therapeutics LTD. 6-K Filing — 6-K · Nov 18, 2025
- Enlivex Therapeutics Files 6-K with Financials — 6-K · Nov 14, 2025
- Enlivex Therapeutics LTD. 6-K Filing — 6-K · Nov 10, 2025
- Enlivex Therapeutics Ltd. Files 6-K Report — 6-K · Sep 25, 2025
- Enlivex Therapeutics Ltd. CEO Letter to Shareholders — 6-K · Sep 11, 2025
- Enlivex Therapeutics Secures Israeli Patent for Cancer Drug — 6-K · Sep 9, 2025
- Enlivex Therapeutics Files 6-K Update — 6-K · Aug 29, 2025
- Enlivex Therapeutics Reports Positive Phase 2b Data — 6-K · Aug 18, 2025
- Enlivex Therapeutics to Host Webinar on August 18 — 6-K · Aug 14, 2025
- Enlivex Therapeutics Completes Phase II COVID-19 Trial Enrollment — 6-K · Jul 28, 2025
- Enlivex Therapeutics Files 6-K with Financials — 6-K · May 30, 2025
- Enlivex Therapeutics Files 2024 Annual Report — 20-F · Apr 30, 2025
- Enlivex Therapeutics to Present at OARSI 2025 World Congress — 6-K · Apr 23, 2025
- Enlivex Completes Patient Enrollment for Phase II COVID-19 Trial — 6-K · Apr 21, 2025
- Enlivex Doses First Patient in Phase I Trial — 6-K · Apr 3, 2025
- Enlivex Therapeutics Files 2024/2023 Financial Statements — 6-K · Mar 31, 2025
- Enlivex Therapeutics Secures China Patent Allowance for Sepsis Treatment — 6-K · Mar 17, 2025
- Enlivex Therapeutics to Discuss Phase I Trial Data — 6-K · Mar 4, 2025
- Enlivex Therapeutics Reports Positive Phase II Trial Data — 6-K · Mar 3, 2025
- Enlivex Therapeutics Addresses Fraudulent News — 6-K · Feb 18, 2025